FIELD: medical engineering.
SUBSTANCE: pill taken per os comprises pharmaceutically active agent selectable from (S,S)-Reboxetin or its salt and Pramipexol or its salt. The pharmaceutically active agent is taken in the amount of 0.01% by mass to 25% by mass of composition. It is dispersed in matrix composed of hydrophilic polymer and starch having rupture strength of at least approximately 0.15 kN·cm-2, at least approximately 0.175 kN·cm-2 or at least approximately 0.2 kN·cm-2, when having solid substance usable for producing pills where hydrophilic polymer takes approximately 20-70% by mass and starch is available in the amount of approximately 25-75% by mass. Method involves determining starch usability and composition applicability for treating the cases of disorders and states selected from depressive psychosis, neuropathic pains and Parkinson disease. Starch of specified rupture strength allows pill to withstand high speed pelletization operation and to provide prolonged drug release and to take a pill once a day.
EFFECT: controlled and prolonged drug action; enhanced effectiveness of treatment.
21 cl, 9 tbl
Title | Year | Author | Number |
---|---|---|---|
SOLID PHARMACEUTICAL PREPARATIVE FORMULATIONS WITH CONTROLLED RELEASE BASED ON CYCLODEXTRIN SULFOALKYL ESTERS | 2000 |
|
RU2233176C9 |
SYSTEM FOR PROLONGED RELEASE OF SOLUBLE DRUG | 2002 |
|
RU2322263C2 |
PARKINSON'S DISEASE THERAPY WITH APPLICATION OF COMBINATION WITH FIXED DOSES | 2013 |
|
RU2642962C9 |
MEDICINE DELIVERY REGULATED SYSTEM CONTAINED IN STOMACH | 2002 |
|
RU2325152C2 |
PARKINSON'S DISEASE THERAPY USING COMBINATION WITH FIXED DOSAGES | 2013 |
|
RU2771522C2 |
DRUG COMPOSITIONS CONTAINING CONTROLLED RELEASE HYPROMELLOSE MATRIXES | 2006 |
|
RU2414241C2 |
NIACIN-CONTAINING PHARMACEUTICAL COMPOSITION (VERSIONS) AND TABLET PREPARATION, METHOD FOR REDUCING HYPEREMIA AND METHOD FOR PREPARING NIACIN-CONTAINING TABLET | 2007 |
|
RU2467750C2 |
PHARMACEUTICAL COMPOSITIONS COMPRISING 5,8,14-TRIAZATETRACYCLO[10,3,1,0(2,11),0(4,9)HEXADECA-2( 11),3,5,7,9-PENTAENE | 2002 |
|
RU2272629C2 |
RASAGILINE COMPOSITIONS OF PROLONGED RELEASE AND USE THEREOF | 2011 |
|
RU2607595C2 |
RASAGILINE COMPOSITIONS WITH PROLONGED RELEASE AND USE THEREOF | 2011 |
|
RU2734632C2 |
Authors
Dates
2007-02-10—Published
2003-07-25—Filed